Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis: A Case Report-Reference-Cited by-同舟云学术

Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis: A Case Report

Published:2023 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yamauchi Hirofumi¹,Momoki Mamiko¹,Kamiyama Yutaro¹,Gunji Tadahiro¹,Yokoyama Hiroki¹,Saito Takeshi¹,Boutboul David²,Oksenhendler Eric²,Yano Shingo¹

Affiliation:

1. Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan

2. Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), France

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_2284-23/_pdf

Reference19 articles.

1. 1. Hodgkin. On some Morbid Appearances of the Absorbent Glands and Spleen. Med Chir Trans 17: 68-114, 1832.

2. 2. Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood 135: 1353-1364, 2020.

3. 3. Nagel S, Scherr M, Quentmeier H, Kaufmann M, Zaborski M, Drexler HG, MacLeod RA. HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia 19: 841-846, 2005.

4. 4. Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard L, Galicier L. The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol 180: 206-216, 2018.

5. 5. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32: 3059-3068, 2014.